BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 35468966)

  • 1. Neuromyotonia with Central Nervous System Lesions following Quadrivalent Human Papilloma Virus Vaccination.
    Hatami M; Förster M; Weyers V; Räuber S; Meuth SG; Kremer D
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    Westra TA; Stirbu-Wagner I; Dorsman S; Tutuhatunewa ED; de Vrij EL; Nijman HW; Daemen T; Wilschut JC; Postma MJ
    BMC Infect Dis; 2013 Feb; 13():75. PubMed ID: 23390964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis.
    Zhang L; Yu K; Zhu B; Mei S; Huo J; Zhao Z
    Hum Vaccin Immunother; 2023 Dec; 19(1):2207441. PubMed ID: 37158187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Cancer and Human Papillomavirus Awareness among Women in Antigua and Barbuda.
    Honnavar P; Mansoor E; Tulloch C; Udayan U; Cosmello I; Patel P; Bersma A
    Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37512042
    [No Abstract]   [Full Text] [Related]  

  • 5. HPV vaccination - a paradigm shift in public health.
    May J
    Aust Fam Physician; 2007 Mar; 36(3):106-11. PubMed ID: 17339969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single vaccine shot protects against cervical cancer.
    O'Leary K
    Nat Med; 2022 Apr; ():. PubMed ID: 35468966
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and other milestones for human papillomavirus vaccine introduction.
    Pagliusi SR; Teresa Aguado M
    Vaccine; 2004 Dec; 23(5):569-78. PubMed ID: 15630792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge.
    Wang R; Pan W; Jin L; Huang W; Li Y; Wu D; Gao C; Ma D; Liao S
    Cancer Lett; 2020 Feb; 471():88-102. PubMed ID: 31812696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.
    McKeage K; Romanowski B
    Drugs; 2011 Mar; 71(4):465-88. PubMed ID: 21395359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
    ; Collins Y; Einstein MH; Gostout BS; Herzog TJ; Massad LS; Rader JS; Wright J
    Gynecol Oncol; 2006 Sep; 102(3):552-62. PubMed ID: 16979432
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.